Cost-utility and Physiological Effects of ACT and BATD in Patients With Chronic Pain and Depression

NACompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2022

Conditions
Randomized Controlled Trial
Interventions
BEHAVIORAL

Acceptance and Commitment Therapy (ACT)

Group treatment protocol of 8 weekly 90 minute sessions. Session 1: Presentation of the general concept of ACT therapy. Session 2: Value analysis I. Session 3: Value analysis II. Session 4: Value analysis III. Session 5: Values and feelings. Session 6: Taking a direction. Session 7: Dare and change. Session 8: Ready to act with ACT.

BEHAVIORAL

Behavioral Activation Therapy for Depression (BATD)

"Group treatment protocol of 8 weekly 90 minute sessions. Session 1: Collection of information regarding areas of activity and interaction contexts.~Session 2: Identification of information related to depressive behaviours. Session 3 Obtaining complementary information regarding the characteristics of the history of patient interactions and any contexts.~Session 4: Explanation of the hypotheses of problematic behaviour, its maintenance and change throughout the intervention.~Session 5: Once the 10 target activities have been identified, a record is made to track and their progress weekly.~Session 6: Discussion of what was obtained from the records in general and of the satisfaction obtained, and explanation of the contexts and reinforcers.~Session 7: Psycho-education Session 8: New behaviours, the goals achieved and the maintenance of the weekly activity are inquired about."

OTHER

Treatment as Usual (TAU)

Standard pharmacological treatment usually provided to patients suffering chronic pain and mild-moderate depression.

Trial Locations (2)

08830

Parc Sanitari Sant Joan de Déu (PSSJD), Sant Boi de Llobregat

08003

Parc de Salut Mar, Barcelona

All Listed Sponsors
collaborator

Carlos III Health Institute

OTHER_GOV

lead

Fundació Sant Joan de Déu

OTHER

NCT04140838 - Cost-utility and Physiological Effects of ACT and BATD in Patients With Chronic Pain and Depression | Biotech Hunter | Biotech Hunter